Showing results (2301-2310 of 4,522) with videos related to
Sort By:
Pageof 453
Advances in Therapy|June 12, 2016
Impact of Pre-existing NS5A-L31 or -Y93H Minor Variants on Response Rates in Patients Infected with HCV Genotype-1b Treated with Daclatasvir/AsunaprevirDennis Hernandez, Fei Yu, Xin Huang, et al.Advances in Therapy|June 12, 2016
Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438)Kazuyoshi Otake, Yuuichi Sakurai, Haruyuki Nishida, et al.Advances in Therapy|June 14, 2016
The Role of Intravoxel Incoherent Motion MRI in Predicting Early Treatment Response to Chemoradiation for Metastatic Lymph Nodes in Nasopharyngeal CarcinomaLiyan Lu, Yuehua Li, Wenbin LiAdvances in Therapy|August 11, 2017
Health-Related Quality of Life in Individuals with Down Syndrome: Results from a Non-Interventional Longitudinal Multi-National StudyDiana Rofail, Daniel Froggatt, Rafael de la Torre, et al.Advances in Therapy|September 18, 2017
Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled StudyAnna I Guerdjikova, Brandon Walsh, Kevin Shan, et al.Advances in Therapy|June 18, 2016
Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®)Laura S Gold, Kangho Suh, Patricia B Schepman, et al.Advances in Therapy|April 17, 2016
Cervical Lymph Node Metastasis in Adenoid Cystic Carcinoma of the Larynx: A Collective International ReviewAndrés Coca-Pelaz, Leon Barnes, Alessandra Rinaldo, et al.Advances in Therapy|April 17, 2016
Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid ArthritisZheng-Yi Zhou, Jenny Griffith, Ella Xiaoyan Du, et al.Advances in Therapy|April 17, 2016
FP/FORM Versus FP/SAL Within Clinical Practice: An Updated Budget Impact Analysis in AsthmaEmily Farrington, Alison Saunders, Louise Heron, et al.Advances in Therapy|October 12, 2017
Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection FractionNancy M Albert, Dana A Drzayich Antol, Richard W DeClue, et al.Pageof 453